OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
March 02, 2023
Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.
March 01, 2023
Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.
February 24, 2023
AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.
February 23, 2023
GAO calls for more oversight of institutional review boards in clinical trials.
February 22, 2023
Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.
February 21, 2023
Webinar Date/Time: Thu, Mar 23, 2023 11:00 AM EDT
February 17, 2023
In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.
February 16, 2023
To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
February 15, 2023
Webinar Date/Time: Wed, Mar 1, 2023 11:00 AM EST
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
